Open Access, data capitalism and academic publishing

There is a significant discrepancy between the reality of academic publishing and the optimism of politicians and science functionaries who praise OA as a panacea for all the ills afflicting science culture.

Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials

Men facing prostate cancer screening and treatment need to make critical and highly preference-sensitive decisions that involve a variety of potential benefits and risks. Shared decision-making is considered fundamental for “preference-sensitive” medical decisions.

Overuse of antimicrobial prophylaxis in low-risk patients undergoing transurethral resection of the prostate

Adherence to antimicrobial prophylaxis recommendations of the European Association of Urology effectively reduces infectious complications and resistance rates. The high frequency of antimicrobial resistance in urological patients may reflect inappropriate use of antimicrobial agents and prolonged prophylaxis.

First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results

The authors propose that all suitable Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease should have a trial of LUM/IVA treatment in experienced centres.